Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for Sleep-wake Disturbances in Parkinson's Disease
NCT01178047Phase 4Terminated
- Sponsor
- University of Zurich
- Start
- Sep 2011
- Primary completion
- Oct 2012
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of rasagiline in Parkinson's disease (PD), sponsored by University of Zurich. Started Sep 2011; status: terminated.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01178047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178047.